{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:01:48Z","timestamp":1791813708510,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.diii.2025.04.001","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T07:17:15Z","timestamp":1744787835000},"page":"289-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Laser-focused ablative therapy for prostate cancer and benign prostatic hyperplasia: A review of current applications and future directions"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-2488","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Cornud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M","family":"Walser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelijne CC","family":"de Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Galiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2025.04.001_bib0001","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.diii.2018.08.002","article-title":"MR imaging-guided prostate interventional imaging: ready for a clinical use?","volume":"99","author":"Cornud","year":"2018","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.04.001_bib0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/fon-2016-0229","article-title":"Focal therapy as primary treatment for localized prostate cancer: definition, needs and future","volume":"13","author":"Ouzzane","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.diii.2025.04.001_bib0003","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3390\/jcm12051860","article-title":"Transperineal Laser ablation for benign prostatic enlargement: a systematic review and pooled analysis of pilot studies","volume":"12","author":"Tafuri","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.diii.2025.04.001_bib0004","article-title":"Real-time multislice MR-thermometry of the prostate: assessment of feasibility, accuracy and sources of biases in patients","author":"Marcelin","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.04.001_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajur.2023.07.001","article-title":"Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: the results of a Delphi consensus project","volume":"11","author":"Cocci","year":"2024","journal-title":"Asian J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jvir.2018.09.016","article-title":"Focal laser ablation of prostate cancer: results in 120 patients with low- to intermediate-risk disease","volume":"30","author":"Walser","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233371","article-title":"MRI-directed micro-US-guided transperineal focal laser ablation for localized prostate cancer: a 1-year follow-up study","volume":"313","author":"Cornud","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2025.04.001_bib0008","first-page":"703","article-title":"MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging","volume":"8","author":"Bomers","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0009","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.eururo.2010.03.008","article-title":"Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy","volume":"57","author":"Lindner","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.euros.2022.02.012","article-title":"Safety and feasibility of Soractelite transperineal focal Laser ablation for prostate cancer and short-term quality of life analysis from a multicenter pilot study","volume":"39","author":"van Riel","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.diii.2025.04.001_bib0011","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.euros.2023.06.002","article-title":"Reliable visualization of the treatment effect of transperineal focal laser ablation in prostate cancer patients by magnetic resonance imaging and contrast-enhanced ultrasound imaging","volume":"54","author":"van Riel","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.diii.2025.04.001_bib0012","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/lsm.23834","article-title":"Outcomes of CEM43 in predicting thermal damage induced by focal laser ablation in controlled ex vivo experiments: a comparison to histology and MRI","volume":"56","author":"de Bie","year":"2024","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.diii.2025.04.001_bib0013","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.juro.2016.07.074","article-title":"Phase II evaluation of magnetic resonance imaging guided focal Laser ablation of prostate cancer","volume":"196","author":"Eggener","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0014","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5152\/dir.2021.20095","article-title":"MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up","volume":"27","author":"Mehralivand","year":"2021","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1148\/radiol.13121652","article-title":"MR imaging-guided focal laser ablation for prostate cancer: phase I trial","volume":"267","author":"Oto","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2025.04.001_bib0016","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.urology.2021.03.054","article-title":"5-year outcomes following focal laser ablation of prostate cancer","volume":"155","author":"Chao","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.diii.2025.04.001_bib0017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.euo.2018.03.011","article-title":"Two-year outcomes following focal laser ablation of localized prostate cancer","volume":"1","author":"Chao","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.diii.2025.04.001_bib0018","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.eururo.2015.04.029","article-title":"Complications, recovery, and early functional outcomes and oncologic control following in-bore focal Laser ablation of prostate cancer","volume":"68","author":"Lepor","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2015.12.083","article-title":"Focal laser ablation of prostate cancer: phase I clinical trial","volume":"196","author":"Natarajan","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2025.01.043","article-title":"MRI-guided transrectal focal laser ablation for localized low- and intermediate risk prostate cancer: initial outcomes using an integrated laser ablation system","author":"Wimper","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0021","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/ans.15526","article-title":"Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy","volume":"89","author":"Al-Hakeem","year":"2019","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.diii.2025.04.001_bib0022","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00345-019-02636-7","article-title":"Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project","volume":"37","author":"van Luijtelaar","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0023","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.juro.2011.03.147","article-title":"Characterizing clinically significant prostate cancer using template prostate mapping biopsy","volume":"186","author":"Ahmed","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0024","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/cancers17030475","article-title":"Anatomic and clinical effects of focal laser ablation of the prostate on symptomatic benign prostatic hyperplasia","volume":"17","author":"Walser","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.diii.2025.04.001_bib0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","article-title":"Focal therapy: patients, interventions, and outcomes: a report from a consensus meeting","volume":"67","author":"Donaldson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0026","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.juro.2015.02.080","article-title":"Image guided focal therapy of MRI-visible prostate cancer: defining a 3D treatment margin based on MRI-histology co-registration analysis","volume":"194","author":"Le Nobin","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0027","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00330-015-3894-x","article-title":"What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?","volume":"26","author":"De Visschere","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0028","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.juro.2017.04.017","article-title":"Focal laser ablation of prostate cancer: feasibility of MRI\/US fusion for guidance","volume":"198","author":"Natarajan","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0029","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1007\/s00330-022-08788-2","article-title":"Post-MRI transrectal micro-ultrasonography of transition zone PI-RADS >2 lesions for biopsy guidance","volume":"32","author":"Cornud","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0030","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1007\/s00330-020-06882-x","article-title":"MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study","volume":"30","author":"Cornud","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0031","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1089\/end.2024.0776","article-title":"Transperineal MR fusion laser ablation of prostate cancer in office setting: one-year efficacy and safety outcomes in intermediate-risk patients","volume":"39","author":"Maiolino","year":"2025","journal-title":"J Endourol"},{"key":"10.1016\/j.diii.2025.04.001_bib0032","article-title":"Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis","author":"Alberti","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.diii.2025.04.001_bib0033","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4081\/aiua.2022.4.406","article-title":"A single-operator experience using EchoLaser SoracteLite for focal laser ablation of prostate cancer: one more arrow in the quiver for the conservative management of the disease","volume":"94","author":"Meneghetti","year":"2022","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.diii.2025.04.001_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers16152620","article-title":"Transperineal Laser ablation for focal therapy of localized prostate cancer: 12-month follow-up outcomes from a single prospective cohort study","volume":"16","author":"Iacovelli","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.diii.2025.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3390\/cancers16071404","article-title":"Transperineal laser ablation treatment of focal low-intermediate risk prostate cancer","volume":"16","author":"Manenti","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.diii.2025.04.001_bib0036","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diii.2023.01.012","article-title":"Long-term outcomes of prostate artery embolization for acute urinary retention: an analysis of 88 patients","volume":"104","author":"Marchi","year":"2023","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.04.001_bib0037","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diii.2024.02.003","article-title":"Prostate artery embolization using liquid embolic agents: is it the future or just a trend?","volume":"105","author":"Boeken","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.04.001_bib0038","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diii.2023.12.006","article-title":"Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: a six-month outcome analysis in 103 patients","volume":"105","author":"Loffroy","year":"2024","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2025.04.001_bib0039","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41391-019-0196-4","article-title":"Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study: results at 6 and 12 months from a retrospective multi-centric study","volume":"23","author":"Pacella","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.diii.2025.04.001_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eururo.2020.08.018","article-title":"Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction","volume":"80","author":"de Rienzo","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41747-021-00239-9","article-title":"3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia","volume":"5","author":"Manenti","year":"2021","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.diii.2025.04.001_bib0042","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00345-023-04322-1","article-title":"Ultrasound-guided SoracteLite transperineal laser ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a prospective single-center experience","volume":"41","author":"Lagana","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0043","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00345-024-05077-z","article-title":"Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study","volume":"42","author":"Lo Re","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.diii.2025.04.001_bib0044","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jvir.2024.04.023","article-title":"Transperineal laser ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up in 40 patients","volume":"35","author":"Patelli","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2025.04.001_bib0045","first-page":"1","article-title":"Transperineal laser ablation as treatment for benign prostatic obstruction: safety, feasibility and functional outcomes","volume":"5","author":"van Kollenburg","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.diii.2025.04.001_bib0046","doi-asserted-by":"crossref","first-page":"471","DOI":"10.23736\/S2724-6051.23.05270-9","article-title":"Three years outcomes of transperineal laser ablation of the prostate","volume":"75","author":"Minafra","year":"2023","journal-title":"Minerva Urol Nephrol"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568425000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568425000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:38:20Z","timestamp":1788262700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568425000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2211568425000725"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2025.04.001","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laser-focused ablative therapy for prostate cancer and benign prostatic hyperplasia: A review of current applications and future directions","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2025.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radiologie.","name":"copyright","label":"Copyright"}]}}